Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancerBrittney S. Harrington, John D. Hooper|British Journal of Cancer|2016Cited by 82
The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2Mark N. Adams, John D. Hooper|PLoS ONE|2011Cited by 52
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S. Harrington, John D. Hooper|Theranostics|2020Cited by 31
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal CancerTahleesa Cuda, John D. Hooper|Contrast Media & Molecular Imaging|2021Cited by 5
Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734Andreas Wortmann, John D. Hooper|Journal of Biological Chemistry|2011Cited by 4